These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32829344)

  • 1. [Management of Cancer Genomic Board and Preparation of Genomic Report].
    Nakamura K; Nishihara H
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1141-1148. PubMed ID: 32829344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
    Tafe LJ; Gorlov IP; de Abreu FB; Lefferts JA; Liu X; Pettus JR; Marotti JD; Bloch KJ; Memoli VA; Suriawinata AA; Dragnev KH; Fadul CE; Schwartz GN; Morgan CR; Holderness BM; Peterson JD; Tsongalis GJ; Miller TW; Chamberlin MD
    Oncologist; 2015 Sep; 20(9):1011-8. PubMed ID: 26205736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
    Kanai M
    Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Precision Medicine Provided by National Health Insurance].
    Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronological improvement in precision oncology implementation in Japan.
    Sunami K; Naito Y; Komine K; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Saigusa Y; Yoshino T
    Cancer Sci; 2022 Nov; 113(11):3995-4000. PubMed ID: 35976133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
    Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T
    Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
    Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
    Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
    Rodriguez-Rodriguez L; Hirshfield KM; Rojas V; DiPaola RS; Gibbon D; Hellmann M; Isani S; Leiser A; Riedlinger GM; Wagreich A; Ali SM; Elvin JA; Miller VA; Ganesan S
    Gynecol Oncol; 2016 Apr; 141(1):2-9. PubMed ID: 27016222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and Outcomes of a Molecular Tumor Board at Herbert-Herman Cancer Center, Sparrow Hospital.
    Trivedi H; Acharya D; Chamarthy U; Meunier J; Ali-Ahmad H; Hamdan M; Herman J; Srkalovic G
    Acta Med Acad; 2019 Apr; 48(1):105-115. PubMed ID: 31264438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Role of Core Hospital of Cancer Genomic Medicine and Regional Cooperation].
    Shirota H; Komine K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1149-1152. PubMed ID: 32829345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Sunami K
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current Status and Prospects of the Comprehensive Cancer Genome Profiling].
    Imoto I; Fukue M; Takaiso N
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):7-11. PubMed ID: 33468714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current Status and Issues of Companion Diagnostics in Cancer Genomic Medicine].
    Kanai M
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):388-391. PubMed ID: 38644302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
    Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
    Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current Status and Future Direction of Cancer Genomic Medicine].
    Nishio K; Sakai K
    Gan To Kagaku Ryoho; 2019 Sep; 46(9):1357-1360. PubMed ID: 31530770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects and Problems of Cancer Genome Analysis for Establishing Cancer Precision Medicine.
    Hayashi T; Konishi I
    Cancer Invest; 2019; 37(9):427-431. PubMed ID: 31451055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.